J A Cervilla1, M Prince, A Mann. 1. Section of Epidemiology and General Practice, Institute of Psychiatry, King's College, University of London, UK. dmedica@sanluis.org
Abstract
OBJECTIVES: Recent longitudinal studies have reported that smoking increases risk for cognitive impairment and that moderate alcohol intake could be preventive. The association between both cigarette smoking and alcohol drinking and incident cognitive impairment was studied in a representative population. METHODS: This is a 1 year prospective population based cohort study of all residents aged 65 or over in the electoral ward of Gospel Oak in London, UK (n=889). Cognitive impairment was assessed at baseline and 1 year later using the organic brain syndrome (OBS) cognitive impairment scale from the short CARE structured assessment. Subjects who were cognitively impaired at baseline were excluded from this analysis. RESULTS: The prevalence of OBS cognitive impairment was 10.4% at index assessment and the 1 year cumulative incidence of cognitive impairment was 5.7%. Cognitive impairment was not associated with use of alcohol, although there was a non-significant association in the direction of a protective effect against onset of cognitive impairment for moderate drinkers compared with non-drinkers and heavy drinkers. Current smoking status predicted cognitive impairment (risk ratio (RR) 3.7; (95% confidence interval (95% CI)=1.1-12.3) independently from sex, age, alcohol, occupational class, education, handicap, depression, and baseline cognitive function. CONCLUSIONS: Smoking seems to be a prospective risk factor for incident cognitive impairment; thus encouragement of older people to stop smoking could be considered as part of a strategy to reduce the incidence of cognitive impairment.
OBJECTIVES: Recent longitudinal studies have reported that smoking increases risk for cognitive impairment and that moderate alcohol intake could be preventive. The association between both cigarette smoking and alcohol drinking and incident cognitive impairment was studied in a representative population. METHODS: This is a 1 year prospective population based cohort study of all residents aged 65 or over in the electoral ward of Gospel Oak in London, UK (n=889). Cognitive impairment was assessed at baseline and 1 year later using the organic brain syndrome (OBS) cognitive impairment scale from the short CARE structured assessment. Subjects who were cognitively impaired at baseline were excluded from this analysis. RESULTS: The prevalence of OBS cognitive impairment was 10.4% at index assessment and the 1 year cumulative incidence of cognitive impairment was 5.7%. Cognitive impairment was not associated with use of alcohol, although there was a non-significant association in the direction of a protective effect against onset of cognitive impairment for moderate drinkers compared with non-drinkers and heavy drinkers. Current smoking status predicted cognitive impairment (risk ratio (RR) 3.7; (95% confidence interval (95% CI)=1.1-12.3) independently from sex, age, alcohol, occupational class, education, handicap, depression, and baseline cognitive function. CONCLUSIONS: Smoking seems to be a prospective risk factor for incident cognitive impairment; thus encouragement of older people to stop smoking could be considered as part of a strategy to reduce the incidence of cognitive impairment.
Authors: P C Elwood; J E Gallacher; C A Hopkinson; J Pickering; P Rabbitt; B Stollery; C Brayne; F A Huppert; A Bayer Journal: J Epidemiol Community Health Date: 1999-01 Impact factor: 3.710
Authors: L A Amaducci; L Fratiglioni; W A Rocca; C Fieschi; P Livrea; D Pedone; L Bracco; A Lippi; C Gandolfo; G Bino Journal: Neurology Date: 1986-07 Impact factor: 9.910
Authors: A B Graves; C M van Duijn; V Chandra; L Fratiglioni; A Heyman; A F Jorm; E Kokmen; K Kondo; J A Mortimer; W A Rocca Journal: Int J Epidemiol Date: 1991 Impact factor: 7.196
Authors: M Fernanda Lima-Costa; Erico Castro-Costa; Elizabeth Uchôa; Joselia Firmo; Antonio Luiz P Ribeiro; Cleusa P Ferri; Martin Prince Journal: Neuroepidemiology Date: 2008-12-16 Impact factor: 3.282
Authors: Jennifer M Glass; Anne Buu; Kenneth M Adams; Joel T Nigg; Leon I Puttler; Jennifer M Jester; Robert A Zucker Journal: Addiction Date: 2009-01 Impact factor: 6.526